embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
19. Dezember 2024 17:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on...
Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs
26. November 2024 06:30 ET
|
Embecta Corp.
PARSIPPANY, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three- and...
embecta Announces Quarterly Cash Dividend
26. November 2024 06:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding...
UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
12. November 2024 17:31 ET
|
Embecta Corp.
PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call...
embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
12. November 2024 17:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call...
embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell
07. November 2024 06:30 ET
|
Embecta Corp.
embecta will be joined by diabetes advocacy groups to ring the Nasdaq Closing Bell today in recognition of National Diabetes Awareness Month in November.
embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes
03. September 2024 06:30 ET
|
Embecta Corp.
embecta has received 510(k) clearance from the FDA for its proprietary disposable insulin delivery system, a patch pump with a 300-unit insulin reservoir.
embecta to Participate in Investor Events
22. August 2024 17:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that...
Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results
09. August 2024 06:30 ET
|
Embecta Corp.
PARSIPPANY, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and nine...
embecta Announces Quarterly Cash Dividend
09. August 2024 06:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding...